ZKSCAN1 and non-small cell lung carcinoma: Furthermore, Wang et al. (2019b) found that circ-ZKSCAN1 could reduce mir-330-5p activity and promote FAM83A expression, leading to inhibition of the MAPK signaling pathway and thus promoting NSCLC progression.